Literature DB >> 25316305

Folic acid prevents depressive-like behavior induced by chronic corticosterone treatment in mice.

Priscila B Rosa1, Camille M Ribeiro1, Luis E B Bettio1, André Colla1, Vicente Lieberknecht1, Morgana Moretti2, Ana Lúcia S Rodrigues1.   

Abstract

The objective of this study was to investigate the effects of folic acid on depressive-like behavior induced by chronic administration of corticosterone in mice. Corticosterone (20mg/kg, p.o.) was administered once a day for 21days. Folic acid (30mg/kg, p.o.) or fluoxetine (10mg/kg, positive control, p.o.) was administered immediately after corticosterone injection during the last 7days of corticosterone treatment. On the 22nd day, animals were submitted to tail suspension test, open-field test and splash test. Corticosterone treatment caused a depressive-like behavior, evidenced by increased immobility time in the tail suspension test and decreased time in which mice spent grooming in the splash test. Repeated folic acid or fluoxetine administration significantly abolished corticosterone-induced depressive-like behavior. Chronic administration of corticosterone decreased levels of serum corticosterone in mice. Neither folic acid, nor fluoxetine treatment reversed this impairment. These findings indicate a robust effect of folic acid in reversing behavioral alterations induced by corticosterone model of depression in mice, suggesting that this vitamin may be an alternative approach for the management of depressive symptoms.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antidepressant; Corticosterone; Depression; Folic acid; Stress

Mesh:

Substances:

Year:  2014        PMID: 25316305     DOI: 10.1016/j.pbb.2014.10.003

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  16 in total

1.  Intracerebroventricular Administration of Streptozotocin as an Experimental Approach to Depression: Evidence for the Involvement of Proinflammatory Cytokines and Indoleamine-2,3-Dioxygenase.

Authors:  Leandro Cattelan Souza; Cristiano R Jesse; Marcelo Gomes de Gomes; Cristini Escobar Viana; Etiara Mattos; Neici Cáceres Silva; Silvana Peterini Boeira
Journal:  Neurotox Res       Date:  2017-02-02       Impact factor: 3.911

2.  Effects of cholecalciferol on behavior and production of reactive oxygen species in female mice subjected to corticosterone-induced model of depression.

Authors:  Suene Vanessa da Silva Souza; Priscila Batista da Rosa; Vivian Binder Neis; Júlia Dubois Moreira; Ana Lúcia S Rodrigues; Morgana Moretti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-08-28       Impact factor: 3.000

3.  Agmatine, by Improving Neuroplasticity Markers and Inducing Nrf2, Prevents Corticosterone-Induced Depressive-Like Behavior in Mice.

Authors:  Andiara E Freitas; Javier Egea; Izaskun Buendia; Vanessa Gómez-Rangel; Esther Parada; Elisa Navarro; Ana Isabel Casas; Aneta Wojnicz; José Avendaño Ortiz; Antonio Cuadrado; Ana Ruiz-Nuño; Ana Lúcia S Rodrigues; Manuela G Lopez
Journal:  Mol Neurobiol       Date:  2015-05-13       Impact factor: 5.590

4.  Involvement of serotonergic neurotransmission in the antidepressant-like effect elicited by cholecalciferol in the chronic unpredictable stress model in mice.

Authors:  Vivian B Neis; Isabel Werle; Morgana Moretti; Priscila B Rosa; Anderson Camargo; Yasmim de O Dalsenter; Nicolle Platt; Axel F Rosado; William D Engel; Gudrian Ricardo L de Almeida; Ingrid Selhorst; Alcir Luiz Dafre; Ana Lúcia S Rodrigues
Journal:  Metab Brain Dis       Date:  2022-04-18       Impact factor: 3.655

5.  Creatine, Similar to Ketamine, Counteracts Depressive-Like Behavior Induced by Corticosterone via PI3K/Akt/mTOR Pathway.

Authors:  Francis L Pazini; Mauricio P Cunha; Julia M Rosa; André R S Colla; Vicente Lieberknecht; Ágatha Oliveira; Ana Lúcia S Rodrigues
Journal:  Mol Neurobiol       Date:  2015-12-11       Impact factor: 5.590

6.  Nutritional psychoneuroimmunology: Is the inflammasome a critical convergence point for stress and nutritional dysregulation?

Authors:  Albert E Towers; Gregory G Freund
Journal:  Curr Opin Behav Sci       Date:  2019-02-23

7.  Dexmedetomidine Ameliorates Sleep Deprivation-Induced Depressive Behaviors in Mice.

Authors:  Eun-Jin Moon; Il-Gyu Ko; Sung-Eun Kim; Jun-Jang Jin; Lakkyong Hwang; Chang-Ju Kim; Hyeonjun An; Bong-Jae Lee; Jae-Woo Yi
Journal:  Int Neurourol J       Date:  2018-10-31       Impact factor: 2.835

8.  Fecal dysbiosis associated with colonic hypersensitivity and behavioral alterations in chronically Blastocystis-infected rats.

Authors:  Frédéric Antonio Carvalho; Philippe Poirier; Manon Defaye; Céline Nourrisson; Elodie Baudu; Amandine Lashermes; Maëva Meynier; Mathieu Meleine; Ivan Wawrzyniak; Virginie Bonnin; Julie Barbier; Benoit Chassaing; Catherine Godfraind; Agathe Gelot; Nicolas Barnich; Denis Ardid; Mathilde Bonnet; Frédéric Delbac
Journal:  Sci Rep       Date:  2020-06-04       Impact factor: 4.379

9.  Naturally Derived Polyphenols Protect Against Corticosterone-Induced Changes in Primary Cortical Neurons.

Authors:  Francisco Donoso; Valerie T Ramírez; Anna V Golubeva; Gerard M Moloney; Catherine Stanton; Timothy G Dinan; John F Cryan
Journal:  Int J Neuropsychopharmacol       Date:  2019-12-01       Impact factor: 5.176

10.  Long-term stability and characteristics of behavioral, biochemical, and molecular markers of three different rodent models for depression.

Authors:  Han Zhu; Yanlin Tao; Tingting Wang; Jin Zhou; Yingwen Yang; Lin Cheng; Huirong Zhu; Weiqi Zhang; Fei Huang; Xiaojun Wu
Journal:  Brain Behav       Date:  2019-12-22       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.